 Dec.16 -- Nithya Balasubramanian, health-care analyst at Bernstein, discusses the prospects for Covid-19 vaccine approvals in India, and the outlook for the countrys pharmaceutical industry. She speaks with Rishaad Salamat and Juliette Saly during the India Focus segment on Bloomberg Markets: Asia. 